Legal Representation
Attorney
Melissa A. Nowak
USPTO Deadlines
Next Deadline
2158 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-07-01)
Due Date
July 01, 2031
Grace Period Ends
January 01, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
36 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 16, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jul 1, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 1, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 11, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| May 15, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| May 15, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Feb 26, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Feb 25, 2025 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Feb 11, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 24, 2025 | CHPB | I | POST PUBLICATION AMENDMENT - ENTERED | Loading... |
| Jan 21, 2025 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Dec 17, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 17, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 11, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 3, 2024 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
| Nov 19, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 19, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 19, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 19, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Nov 19, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Oct 29, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 29, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 29, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 24, 2024 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Sep 24, 2024 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| Sep 7, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 6, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 6, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 6, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 21, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 21, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 21, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 21, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 1, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 1, 2024 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jan 25, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations in the field of gynecology and women's health, namely, contraceptive preparations and oral contraceptives; hormone replacement therapy preparations containing estradiol and progesterone for use in treating the symptoms associated with menopause; pharmaceutical preparations for the treatment of vulval vaginal atrophy; antibiotic preparations; pharmaceutical preparations for the treatment of dermatological diseases and disorders; topical foam pharmaceutical preparations for treatment of steroid responsive dermatoses; pharmaceutical preparations for the treatment of rosacea and erythema associated with rosacea; pharmaceutical preparations for the treatment of psoriasis; antifungal preparations; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical substances and preparations for the treatment of cancer; dietary and nutritional supplements; vitamins
First Use Anywhere:
Apr 27, 2018
First Use in Commerce:
Apr 27, 2018
Class 010
contraceptive apparatus in the field of gynecology and women's health
First Use Anywhere:
Aug 21, 2024
First Use in Commerce:
Aug 21, 2024
Additional Information
Design Mark
The mark consists of the wording "MAYNE PHARMA" and a circle design. The wording "MAYNE" is within a shaded circle. The wording "PHARMA" is to the right of the circle.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
010
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"